All.Can International shared a post by Liora Bowers, Health Policy Analyst of OECD – OCDE, on LinkedIn, adding:
“OECD report reinforces efficiency as a cornerstone of high-value cancer care – at a critical moment for EU investment decisions!
The OECD – OCDE has published Delivering High-Value Cancer Care, underlining that better cancer outcomes depend not only on innovation and access, but on how efficiently health systems use available resources. Timely care, evidence-based pathways and people-centred approaches are identified as essential to deliver value and sustainability.
This message comes as Europe enters discussions on the next EU Multiannual Financial Framework (MFF). With constrained budgets and competing priorities, the report reinforces a key point: efficiency is not cost-cutting, but smart investment to maximize outcomes for people with cancer and for society. This directly reinforces All.Can International’s long-standing work, which defines efficient cancer care as delivering the best possible outcomes using available resources, focused on what truly matters to patients.
Against this backdrop, All.Can’s upcoming policy event offers a timely space to connect OECD evidence with concrete EU policy and funding choices, and to discuss how efficiency can be embedded in cancer plans and future EU investment frameworks, including the MFF.
Event pre-registration now open, details available in comments below.”
Quoting Liora Bowers‘s post:
“Check out our latest OECD Report on Delivering High Value Cancer Care, released today!
A huge thank you to the many organizations and partners that provided input and insights on this report. May it support faster, more effective, people-centered care for the 2.7 million new cancer patients in the EU annually.”
More posts featuring All.Can International on OncoDaily.